Abstract
We report here a series of new inhibitors of the X-linked inhibitor of apoptosis protein (XIAP protein) based on the SMAC-tetrapeptide AVPI. The structural novelty of these molecules is the presence of the proline mimetic exo-2-azabicyclo[2.2.1]heptane-3-carboxylic acid, leading to analogs with similar activity to the natural ligand peptide. The structure-activity relationship and computational docking studies support the convenience of this unnatural amino acid as a building block to develop new peptides or small molecules targeting the XIAP-BIR3 domain.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Apoptosis*
-
Bridged Bicyclo Compounds / metabolism
-
Humans
-
Models, Molecular
-
Molecular Biology / methods*
-
Molecular Dynamics Simulation
-
Peptides / chemistry
-
Peptides / metabolism
-
Proline / analogs & derivatives
-
Structure-Activity Relationship
-
X-Linked Inhibitor of Apoptosis Protein / antagonists & inhibitors*
-
X-Linked Inhibitor of Apoptosis Protein / metabolism*
Substances
-
2-azabicyclo(2.2.1)heptane-3-carboxylic acid
-
Bridged Bicyclo Compounds
-
Peptides
-
X-Linked Inhibitor of Apoptosis Protein
-
XIAP protein, human
-
Proline